Effect of cyclodextrin on the pharmacology of antifungal oral azoles

Antimicrob Agents Chemother. 1992 Feb;36(2):477-80. doi: 10.1128/AAC.36.2.477.

Abstract

Concentrations of oral azoles in serum were compared in a single-dose pharmacologic study in mice. When hydroxypropyl-beta-cyclodextrin was used as a carrier and compared with a standard carrier, polyethylene glycol, drug concentrations determined by bioassay showed that the peak concentration and area under the concentration-time curve were greatly enhanced for itraconazole and saperconazole; moderately enhanced for ketoconazole; but negligibly affected for fluconazole, miconazole, and SCH 42427.

Publication types

  • Comparative Study

MeSH terms

  • 2-Hydroxypropyl-beta-cyclodextrin
  • Animals
  • Antifungal Agents / pharmacokinetics*
  • Azoles / pharmacokinetics*
  • Biological Availability
  • Cyclodextrins / pharmacology*
  • Drug Carriers
  • Female
  • Mice
  • Polyethylene Glycols
  • beta-Cyclodextrins*

Substances

  • Antifungal Agents
  • Azoles
  • Cyclodextrins
  • Drug Carriers
  • beta-Cyclodextrins
  • 2-Hydroxypropyl-beta-cyclodextrin
  • Polyethylene Glycols